Solo GP with an operator background (Summit Ventures COO) who invests across all stages and differentiates by democratizing access—inviting diverse co‑investors to participate alongside Sequoia and Andreessen Horowitz. The firm continues to build its presence across the venture capital landscape.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Acts as a VC and venture studio—co-founds emerging ventures with 25–30% of capital, assembles top‑1% specialists, and builds national‑capability defense, industrials, and bio‑infrastructure companies with corporate partners. The firm continues to build its presence across the venture capital landscape.
Pre-seed investor writing the first institutional check, operating a Venice entrepreneurial campus where founders and investors co-work, with Hollywood-connected mentors providing direct access to celebrity, media and brand networks. The firm continues to build its presence across the venture capital landscape.
Invests very early (seed, $1–3M) with a solo GP enabling rapid decisions, leveraging an operator-heavy LP network for sourcing and delivering data-driven diagnostics plus structured playbooks to find PMF. The firm continues to build its presence across the venture capital landscape.
Leads seed, doubles down at Series A, and incubates emerging ventures; an unusually operator-heavy founding team (Eventbrite founder, ex-Uber finance head, ex-Coatue investor) features hands-on operational, finance, and growth support. With a disciplined investment approach, the team drives value for both founders and investors.
Venture studio and fund that co‑incubates with LifePoint executives, giving startup ventures direct access to a $50B+ health system for pilot deployment, real‑world validation, and underserved population focus. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Generates operator-generated concepts and recruits elite CEOs, provides codified ideation and structured focus groups, physician GPs with check-writing authority for healthcare, plus 70+ in-house engineers across Montreal and Bogotá. With a clear focus on healthcare innovation, the firm brings both capital and domain expertise.
